Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net income	$ 22,586	$ 1,270
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of capitalized software costs	16,403	17,592
Amortization of debt issuance costs	453	381
Amortization of other intangibles	6,590	9,298
Change in fair value of contingent consideration	(100)	7
Deferred income taxes	463	35
Depreciation	3,841	5,406
Excess tax deficiency (benefit) from share-based compensation	(678)	834
Gain on disposition of Commercial Dental assets	(10,296)
Impairment of assets	1,576	1,577
Loss on disposal of equipment and improvements	74	77
Loss on foreign currency exchange rates	(13)
Non-cash operating lease costs	2,192	4,455
Provision for bad debts	1,100	1,142
Share-based compensation	26,516	18,685
Changes in assets and liabilities, net of amounts acquired:
Accounts receivable	(2,625)	6,319
Contract assets	7,189	(4,786)
Accounts payable	4,117	3,592
Contract liabilities	(4,941)	2,016
Accrued compensation and related benefits	(23,591)	(8,355)
Income taxes	822	(7,214)
Deferred compensation	339	1,051
Operating lease liabilities	(7,425)	(10,062)
Other assets and liabilities	(8,615)	(6,684)
Net cash provided by operating activities	35,977	36,636
Cash flows from investing activities:
Additions to capitalized software costs	(26,906)	(17,837)
Additions to equipment and improvements	(2,058)	(2,037)
Payments for acquisitions, net of cash acquired	(47,451)
Proceeds from disposition of Commercial Dental assets	11,253
Net cash used in investing activities	(65,162)	(19,874)
Cash flows from financing activities:
Proceeds from convertible senior notes	275,000
Proceeds from line of credit	50,000
Repayments on line of credit	(50,000)
Proceeds from issuance of shares under employee plans	5,395	877
Repurchase of common stock	(49,878)	(35,874)
Payment of debt issuance costs	(8,483)
Payment of contingent consideration related to acquisitions		(540)
Payments for taxes related to net share settlement of equity awards	(9,977)	(5,450)
Net cash provided by (used in) financing activities	212,057	(40,987)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(149)
Net increase (decrease) in cash, cash equivalents, and restricted cash	182,723	(24,225)
Cash, cash equivalents, and restricted cash at beginning of period	66,747	78,575
Cash, cash equivalents, and restricted cash at end of period	249,470	54,350
Supplemental disclosures of cash flow information:
Cash paid for income taxes	5,887	8,182
Cash refunds from income taxes	9	119
Cash paid for interest	797	382
Cash paid for amounts included in the measurement of operating lease liabilities	7,973	10,861
Operating lease assets obtained in exchange for operating lease liabilities	957	197
Accrued purchases of equipment and improvements	$ 71	$ 262